Cargando…
Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture
BACKGROUND: Aggregation, fragmentation, and low yield are issues frequently found during the cell culture process of bispecific antibodies (bsAbs), whose inherent complexity likely plays a role in causing these issues. METHODS: In this study, we made a head-to-head comparison between fed-batch cell...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199187/ https://www.ncbi.nlm.nih.gov/pubmed/35719210 http://dx.doi.org/10.1093/abt/tbac009 |
_version_ | 1784727798284288000 |
---|---|
author | Qin, Yongjun Ma, Rongmei Li, Yang Li, Yifeng Chen, Gong Zhou, Weichang |
author_facet | Qin, Yongjun Ma, Rongmei Li, Yang Li, Yifeng Chen, Gong Zhou, Weichang |
author_sort | Qin, Yongjun |
collection | PubMed |
description | BACKGROUND: Aggregation, fragmentation, and low yield are issues frequently found during the cell culture process of bispecific antibodies (bsAbs), whose inherent complexity likely plays a role in causing these issues. METHODS: In this study, we made a head-to-head comparison between fed-batch cell culture and intensified perfusion cell culture with a symmetric bsAb case. RESULTS: In comparison with the fed-batch culture, a 6.6-fold improvement in integrated viable cell density and a 10.9-fold improvement in volumetric productivity were achieved with the intensified perfusion mode. In addition, a significant decrease in aggregation and fragmentation was observed with the intensified perfusion cell culture. Furthermore, product homogeneity was improved, which was reflected by the increased percentage of capillary isoelectric focusing main group. The quality improvement with intensified perfusion cell culture can be attributed to the shortened product retention in the bioreactor. CONCLUSIONS: These findings suggest that intensified perfusion cell culture could be a better choice than traditional fed-batch especially for complex molecules like bsAbs. As this is a single case report, future studies on other cases are needed to further confirm the general applicability of this strategy. |
format | Online Article Text |
id | pubmed-9199187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91991872022-06-16 Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture Qin, Yongjun Ma, Rongmei Li, Yang Li, Yifeng Chen, Gong Zhou, Weichang Antib Ther Original Research Article BACKGROUND: Aggregation, fragmentation, and low yield are issues frequently found during the cell culture process of bispecific antibodies (bsAbs), whose inherent complexity likely plays a role in causing these issues. METHODS: In this study, we made a head-to-head comparison between fed-batch cell culture and intensified perfusion cell culture with a symmetric bsAb case. RESULTS: In comparison with the fed-batch culture, a 6.6-fold improvement in integrated viable cell density and a 10.9-fold improvement in volumetric productivity were achieved with the intensified perfusion mode. In addition, a significant decrease in aggregation and fragmentation was observed with the intensified perfusion cell culture. Furthermore, product homogeneity was improved, which was reflected by the increased percentage of capillary isoelectric focusing main group. The quality improvement with intensified perfusion cell culture can be attributed to the shortened product retention in the bioreactor. CONCLUSIONS: These findings suggest that intensified perfusion cell culture could be a better choice than traditional fed-batch especially for complex molecules like bsAbs. As this is a single case report, future studies on other cases are needed to further confirm the general applicability of this strategy. Oxford University Press 2022-05-03 /pmc/articles/PMC9199187/ /pubmed/35719210 http://dx.doi.org/10.1093/abt/tbac009 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Antibody Therapeutics. All rights reserved. For Permissions, please email: journals.permissions@oup.com https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Research Article Qin, Yongjun Ma, Rongmei Li, Yang Li, Yifeng Chen, Gong Zhou, Weichang Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture |
title | Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture |
title_full | Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture |
title_fullStr | Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture |
title_full_unstemmed | Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture |
title_short | Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture |
title_sort | productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199187/ https://www.ncbi.nlm.nih.gov/pubmed/35719210 http://dx.doi.org/10.1093/abt/tbac009 |
work_keys_str_mv | AT qinyongjun productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture AT marongmei productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture AT liyang productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture AT liyifeng productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture AT chengong productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture AT zhouweichang productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture |